why choose us

First received: January 18, 2023

Clinical Trial: Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance

Study Status: Completed

Recruit Status: RECRUITING

Condition: Fructan Intolerance

Study Type: INTERVENTIONAL


Official Title: A Double-Blind, Placebo-Controlled, Crossover Study of Sacrosidase for the Treatment of Subjects With Fructan Intolerance

Brief Summary: SSDXA-14 is a Phase 2 (feasibility/pilot) double-blind, placebo-controlled, crossover study to evaluate the efficacy and safety of sacrosidase and placebo in 25 subjects objectively diagnosed with fructan intolerance.

Read more